# | Title | Journal | Year | Citations |
---|
1 | Using SIFT and PolyPhen to Predict Loss-of-Function and Gain-of-Function Mutations | Genetic Testing and Molecular Biomarkers | 2010 | 330 |
2 | Public Knowledge of and Attitudes Toward Genetics and Genetic Testing | Genetic Testing and Molecular Biomarkers | 2013 | 195 |
3 | Physicians' Preparedness for Integration of Genomic and Pharmacogenetic Testing into Practice Within a Major Healthcare System | Genetic Testing and Molecular Biomarkers | 2013 | 118 |
4 | Relationship Between Leptin G2548A and Leptin Receptor Q223R Gene Polymorphisms and Obesity and Metabolic Syndrome Risk in Tunisian Volunteers | Genetic Testing and Molecular Biomarkers | 2012 | 89 |
5 | Uptake, Time Course, and Predictors of Risk-Reducing Surgeries inBRCACarriers | Genetic Testing and Molecular Biomarkers | 2009 | 76 |
6 | Screening of 38 Genes Identifies Mutations in 62% of Families with Nonsyndromic Deafness in Turkey | Genetic Testing and Molecular Biomarkers | 2011 | 76 |
7 | Circulating miRNA-20a and miRNA-203 for Screening Lymph Node Metastasis in Early Stage Cervical Cancer | Genetic Testing and Molecular Biomarkers | 2013 | 76 |
8 | Association of the Polymorphisms of Vitamin D Receptor and Aggrecan Genes with Degenerative Disc Disease | Genetic Testing and Molecular Biomarkers | 2010 | 69 |
9 | Species Identification Through DNA “Barcodes” | Genetic Testing and Molecular Biomarkers | 2009 | 67 |
10 | MicroRNA 146a Expression in Rheumatoid Arthritis: Association with Tumor Necrosis Factor–Alpha and Disease Activity | Genetic Testing and Molecular Biomarkers | 2011 | 63 |
11 | Methylenetetrahydrofolate Reductase Polymorphisms C677T and Risk of Autism in the Chinese Han Population | Genetic Testing and Molecular Biomarkers | 2012 | 61 |
12 | Obama's Precision Medicine Initiative | Genetic Testing and Molecular Biomarkers | 2015 | 60 |
13 | Serum Endocan Levels Are Correlated with the Presence and Severity of Coronary Artery Disease in Patients with Hypertension | Genetic Testing and Molecular Biomarkers | 2015 | 59 |
14 | The R1141X Loss-of-Function Mutation of the ABCC6 Gene Is a Strong Genetic Risk Factor for Coronary Artery Disease | Genetic Testing and Molecular Biomarkers | 2010 | 57 |
15 | Recurrent Pregnancy Loss and Its Relation to Combined Parental Thrombophilic Gene Mutations | Genetic Testing and Molecular Biomarkers | 2012 | 57 |
16 | A Statewide Survey of Practitioners to Assess Knowledge and Clinical Practices Regarding Hereditary Breast and Ovarian Cancer | Genetic Testing and Molecular Biomarkers | 2013 | 57 |
17 | Knockdown of LncRNA-XIST Suppresses Proliferation and TGF-β1-Induced EMT in NSCLC Through the Notch-1 Pathway by Regulation of miR-137 | Genetic Testing and Molecular Biomarkers | 2018 | 57 |
18 | Cancer Genetic Risk Assessment and Referral Patterns in Primary Care | Genetic Testing and Molecular Biomarkers | 2009 | 55 |
19 | Living Without a Diagnosis: The Parental Experience | Genetic Testing and Molecular Biomarkers | 2010 | 55 |
20 | Public Perspectives About Pharmacogenetic Testing and Managing Ancillary Findings | Genetic Testing and Molecular Biomarkers | 2012 | 55 |
21 | Gene Polymorphisms and Sport Attitude in Italian Athletes | Genetic Testing and Molecular Biomarkers | 2011 | 54 |
22 | MicroRNA-223 Is Upregulated in Active Tuberculosis Patients and Inhibits Apoptosis of Macrophages by Targeting FOXO3 | Genetic Testing and Molecular Biomarkers | 2015 | 54 |
23 | Identification of an Exosomal Long Noncoding RNA SOX2-OT in Plasma as a Promising Biomarker for Lung Squamous Cell Carcinoma | Genetic Testing and Molecular Biomarkers | 2019 | 54 |
24 | Health-Care Referrals from Direct-to-Consumer Genetic Testing | Genetic Testing and Molecular Biomarkers | 2010 | 53 |
25 | A Substitution Involving the NLGN4 Gene Associated with Autistic Behavior in the Greek Population | Genetic Testing and Molecular Biomarkers | 2009 | 50 |
26 | GATA4 Mutations in 357 Unrelated Patients with Congenital Heart Malformation | Genetic Testing and Molecular Biomarkers | 2010 | 50 |
27 | Willingness to Pay for Genetic Testing for Alzheimer's Disease: A Measure of Personal Utility | Genetic Testing and Molecular Biomarkers | 2011 | 50 |
28 | Professional Perspectives About Pharmacogenetic Testing and Managing Ancillary Findings | Genetic Testing and Molecular Biomarkers | 2012 | 49 |
29 | Association Between theMTHFRC677T Polymorphism and Recurrent Pregnancy Loss: A Meta-Analysis | Genetic Testing and Molecular Biomarkers | 2012 | 48 |
30 | Oxidative Stress, Helicobacter pylori, and OGG1 Ser326Cys, XPC Lys939Gln, and XPD Lys751Gln Polymorphisms in a Turkish Population with Colorectal Carcinoma | Genetic Testing and Molecular Biomarkers | 2010 | 47 |
31 | Prediction Value of miR-483 and miR-214 in Prognosis and Multidrug Resistance of Esophageal Squamous Cell Carcinoma | Genetic Testing and Molecular Biomarkers | 2013 | 47 |
32 | Single-Nucleotide Polymorphisms in Genes Encoding Toll-Like Receptor -2, -3, -4, and -9 in Case–Control Study with Breast Cancer | Genetic Testing and Molecular Biomarkers | 2009 | 46 |
33 | Mutations in the CHD7 Gene: The Experience of a Commercial Laboratory | Genetic Testing and Molecular Biomarkers | 2010 | 46 |
34 | Prolactin Receptor Gene Polymorphisms Are Associated with Gestational Diabetes | Genetic Testing and Molecular Biomarkers | 2013 | 46 |
35 | Reforming Biobank Consent Policy: A Necessary Move Away from Broad Consent Toward Dynamic Consent | Genetic Testing and Molecular Biomarkers | 2013 | 46 |
36 | Metabolomic Profiling of Human Urine as a Screen for Multiple Inborn Errors of Metabolism | Genetic Testing and Molecular Biomarkers | 2016 | 46 |
37 | Potential Consumers' Attitudes Toward Psychiatric Genetic Research and Testing and Factors Influencing Their Intentions to Test | Genetic Testing and Molecular Biomarkers | 2009 | 45 |
38 | Recurrent and Private MYO15A Mutations Are Associated with Deafness in the Turkish Population | Genetic Testing and Molecular Biomarkers | 2010 | 45 |
39 | Methylenetetrahydrofolate Reductase Polymorphisms Are Related to Male Infertility in Brazilian Men | Genetic Testing and Molecular Biomarkers | 2011 | 45 |
40 | DNA Repair Genes in Parkinson's Disease | Genetic Testing and Molecular Biomarkers | 2012 | 45 |
41 | Screening of the General Polish Population for Deafness-Associated Mutations in Mitochondrial 12S rRNA and tRNASer(UCN) Genes | Genetic Testing and Molecular Biomarkers | 2009 | 43 |
42 | Polymorphisms of Glutathione-S-Transferase Genes and the Risk of Aerodigestive Tract Cancers in the Northeast Indian Population | Genetic Testing and Molecular Biomarkers | 2010 | 43 |
43 | Attitudes About Regulation Among Direct-to-Consumer Genetic Testing Customers | Genetic Testing and Molecular Biomarkers | 2013 | 43 |
44 | Association of Luteinizing Hormone Chorionic Gonadotropin Receptor Gene Polymorphism (rs2293275) with Polycystic Ovarian Syndrome | Genetic Testing and Molecular Biomarkers | 2015 | 43 |
45 | A Low-Cost Exon Capture Method Suitable for Large-Scale Screening of Genetic Deafness by the Massively-Parallel Sequencing Approach | Genetic Testing and Molecular Biomarkers | 2012 | 42 |
46 | Next-Generation Testing for Cancer Risk: Perceptions, Experiences, and Needs Among Early Adopters in Community Healthcare Settings | Genetic Testing and Molecular Biomarkers | 2015 | 42 |
47 | The Association of MMP-9 Enzyme Activity, MMP-9 C1562T Polymorphism, and MMP-2 and -9 and TIMP-1, -2, -3, and -4 Gene Expression in Lung Cancer | Genetic Testing and Molecular Biomarkers | 2009 | 41 |
48 | High Frequency of the p.R34X Mutation in the TMC1 Gene Associated with Nonsyndromic Hearing Loss Is Due to Founder Effects | Genetic Testing and Molecular Biomarkers | 2010 | 41 |
49 | Serum Markers of Endothelial Dysfunction and Inflammation Increase in Hypertension with Prediabetes Mellitus | Genetic Testing and Molecular Biomarkers | 2016 | 41 |
50 | Direct-to-Consumer Genetic Testing: A Systematic Review of European Guidelines, Recommendations, and Position Statements | Genetic Testing and Molecular Biomarkers | 2015 | 40 |